OR WAIT null SECS
February 14, 2020
The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.
Under the agreement, Roche will have access to Promedior's lead product candidate, PRM-15, a recombinant form of human pentraxin-2 that can possibly treat a range of systemic fibrotic diseases.
February 10, 2020
New funding brings competitors, and a leading healthcare products distributor, into the standardization effort.
February 05, 2020
Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.
February 02, 2020
Bio/pharma researchers mobilize to diagnose and treat patients in pandemic threat.
January 29, 2020
The new facility, to be operated under the newly formed CDMO, The Center for Breakthrough Medicines, will be located in King of Prussia, PA, and will increase manufacturing capacity for cell and gene therapies.
January 27, 2020
Tina Morris will be taking on the role of executive director for AAPS.
The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.
January 23, 2020
The amount was the third highest year recorded and investment has increased more than 400% since 2012.
January 21, 2020
The agreement centers around the development of new stem-cell derived allogeneic T-cell therapies for the treatment of cancer.